Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 22, 2010 7:00 PM 3 min read

HARTE-HANKS INC (HHS) - Profit Tracks

by Web Master Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo
Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why RSG and HHS have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

Here is a synopsis of why AVP and KMB have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
AdvertisingConsumer DiscretionaryConsumer StaplesEnvironmental & Facilities ServicesHousehold ProductsIndustrialsPersonal Products
HHS Logo
HHSHarte-Hanks Inc
$2.834.61%
Overview
KMB Logo
KMBKimberly-Clark Corp
$104.45-0.44%
RSG Logo
RSGRepublic Services Inc
$230.93-0.32%

Republic Services, Inc. (RSG)reported third - quarter earnings of 45 cents per share on Nov 4, which missed the Zacks Consensus Estimate by a penny. The total revenue for 2010 fell from $2,073.5 million by $11.8 million to $2,061.7. The Zacks Consensus Estimate for the full year declined to a profit of $1.70 per share from $1.71 over the past week. Next year?s forecast slipped a penny to $1.92 per share in the same time period. Harte-Hanks, Inc. (HHS)announced third - quarter earnings per share of 22 cents on October 28, which fell short of the Zacks Consensus Estimate by nearly 4%. The diluted earnings per share has remained $0.22 on a year over year basis The Zacks Consensus Estimate for 2010 slipped 5 cents to a profit of 82 cents per share in the last 30 days, which reflected reductions by 3 out of the 4 covering analysts. Next year?s estimate fell 10 cents to 95 cents per share in the same period. Avon Products, Inc. (AVP)On October 28 Avon Products, Inc. reported a profit of 41 cents per share, which lagged the Zacks Consensus Estimate by nearly 6%. The diluted earnings per share decreased 118% to $0.38 on a year ? over ? year basis. The Zacks Consensus Estimate for the present year fell 12 cents to a profit of $1.90 in the past 30 days as all the 14 covering analysts reduced forecasts. Kimberly-Clark Corporation?s (KMB)reported third-quarter earnings of $1.14 per share on October 26, which was 14% short of the average forecast. The earnings per share fell 26 cents to $1.14 on a year over year basis. The Zacks Consensus Estimate for 2010 declined 18 cents to $4.64 per share over the past month as all of the 13 covering analysts revised downward. Next year?s estimate slid 23 cents to $5 per share during that time.
 
AVON PRODS INC (AVP): Free Stock Analysis Report
 
HARTE-HANKS INC (HHS): Free Stock Analysis Report
 
KIMBERLY CLARK (KMB): Free Stock Analysis Report
 
REPUBLIC SVCS (RSG): Free Stock Analysis Report
 
Zacks Investment Research

HHS Logo
HHSHarte-Hanks Inc
$2.834.61%
Overview
KMB Logo
KMBKimberly-Clark Corp
$104.45-0.44%
RSG Logo
RSGRepublic Services Inc
$230.93-0.32%
Comments
Loading...